Audio Hypnotherapy for Preoperative Anxiety and Inflammatory Markers in Elective Cesarean Section

November 10, 2026 updated by: Tjahya Aryasa, Udayana University

The Effect of Hypnotherapy on the Production of Transcription Factor NF-kB, IL-6, IL-10, and Anxiety in Patients Undergoing Cesarean Section: A Randomized Controlled Trial

This randomized controlled trial tests whether listening to an audio hypnotherapy recording before a planned cesarean section reduces preoperative anxiety and changes blood markers of inflammation. Sixty pregnant women scheduled for elective cesarean section under spinal anesthesia at Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Indonesia, will be randomly assigned in a 1:1 ratio to receive either two 30-minute audio hypnotherapy sessions (the evening before surgery and the morning of surgery) or standard care without hypnotherapy. Anxiety will be measured with the Amsterdam Preoperative Anxiety and Information Scale (APAIS). NF-kB, IL-6 and IL-10 will be measured in blood before the intervention and 24 hours after surgery.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Background: Preoperative anxiety is common in women undergoing cesarean section. Anxiety activates the hypothalamic-pituitary-adrenal (HPA) axis and is associated with activation of nuclear factor-kappa B (NF-kB), increased interleukin-6 (IL-6) and decreased interleukin-10 (IL-10). Premedication drugs used to reduce anxiety can cause allergy and sedation, and their fetal safety is debated. Hypnotherapy is a non-pharmacological option, but its effect on both anxiety and inflammatory markers in cesarean section has not been well studied.

Design: Single-center, parallel-group, randomized controlled trial with pretest-posttest measurement. Participants are allocated 1:1 by a computer-generated random sequence concealed in sequentially numbered, sealed, opaque envelopes prepared by a third party not involved in the study.

Procedures: Eligible patients are screened one day before surgery and sign informed consent. Baseline APAIS score and baseline blood samples for NF-kB, IL-6 and IL-10 are collected. The hypnotherapy group listens to a 30-minute hypnotherapy audio recording in the evening before surgery and again in the morning of surgery. The control group receives standard care without hypnotherapy. APAIS is repeated on the morning of surgery before entering the operating room. All patients receive spinal anesthesia and standard postoperative analgesia according to hospital protocol. Blood samples are repeated 24 hours after surgery. IL-6 and IL-10 are measured by ELISA; NF-kB is measured in peripheral blood lymphocytes.

Sample size: 27 per group based on a previous study (mean anxiety difference 5.76, SD 5.19). Allowing 10% dropout, 30 per group (60 total) will be enrolled.

Analysis: Between-group comparisons by independent t-test or Mann-Whitney U test; within-group pre-post comparisons by paired t-test or Wilcoxon test. P < 0.05 is considered significant.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Bali
      • Denpasar, Bali, Indonesia, 80114
        • Prof. Dr. I.G.N.G. Ngoerah General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Pregnant women scheduled for elective cesarean section at Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Bali
  • Planned spinal (subarachnoid block) anesthesia
  • Willing to participate and to sign informed consent

Exclusion Criteria:

  • Emergency cesarean section
  • Planned general anesthesia
  • Use of narcotic or psychotropic drugs
  • Medical conditions affecting the HPA axis, such as endocrine disorders
  • Need for postoperative intensive care unit admission
  • Unwilling to undergo the hypnotherapy intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hypnotherapy Group

Participants listen to a 30-minute pre-recorded audio hypnotherapy session twice: in the evening before surgery and in the morning of surgery, in addition to standard perioperative care.

Pre-recorded hypnotherapy audio with induction, deepening, positive suggestions for calmness and a smooth cesarean section, relaxing background music, and termination. Delivered for 30 minutes on two occasions: the evening before surgery and the morning of surgery.

No Intervention: Control Group

Participants receive standard perioperative care without hypnotherapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Preoperative Anxiety Score (APAIS)
Time Frame: Baseline (day before surgery, before the first session) and morning of surgery (after the second session, before entering the operating room)

Anxiety measured with the Indonesian version of the Amsterdam Preoperative Anxiety and Information Scale (APAIS). Anxiety subscale is the sum of items 1, 2, 4 and 5, each scored 1-5 (total 4-20). Higher scores indicate greater anxiety.

Baseline (day before surgery, before the first session) and morning of surgery (after the second session, before entering the operating room)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in NF-kB Level
Time Frame: Baseline (day before surgery) and 24 hours after surgery

NF-kB measured in peripheral blood lymphocytes isolated from venous blood.

Baseline (day before surgery) and 24 hours after surgery
Change in Serum IL-6
Time Frame: Baseline (day before surgery) and 24 hours after surgery

Serum interleukin-6 measured by ELISA (ng/L).

Baseline (day before surgery) and 24 hours after surgery
Change in Serum IL-10
Time Frame: Baseline (day before surgery) and 24 hours after surgery

Serum interleukin-10 measured by ELISA (pg/mL).

Baseline (day before surgery) and 24 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Tjahya Aryasa EM, MD, Udayana University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 12, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

January 12, 2027

Study Registration Dates

First Submitted

November 10, 2026

First Submitted That Met QC Criteria

November 10, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 10, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 1671/UN14.2.2.VII.14/LT/2026
  • DP.04.03/D.XVI.2.4.1/32522/202 (Other Identifier: Research Permit, Prof. Dr. I.G.N.G. Ngoerah General Hospital)
  • 260505.194 (Other Identifier: Research ID, Prof. Dr. I.G.N.G. Ngoerah General Hospital)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because participant consent did not include data sharing. Aggregated results will be published.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.